Viral co-infections in hepatitis C virus (HCV) infection: HBV, HGV and TTV studies;Víruskoinfekciók krónikus hepatitis C-vírus-fertozésben: HBV-, GBV-C/HGV- és TTV-vizsgálatok

Orvosi Hetilap

Volumn 145, Issue 19, 2004, Pages 987-992

  Pár, Alajos ^a,b   Takács, Mária ^b   Brojnás, Judit ^b   Berencsi, György ^b   Paál, Mária ^c   Horányi, Margit ^d   Miseta, Attila ^a   Hegedus, Géza ^b   Mózsik, Gyula ^a   Hunyady, Béla ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Virológiai Foosztály ^*  (Hungary)

^c Vértranszfúziós Állomás   (Hungary)

^d Országos Gyógyintézeti Központ   (Hungary)

Author keywords

GBV C Hepatitis G virus; Hepatitis B virus; Hepatitis C virus; Interferon therapy; Viral co infections

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; ANTIVIRUS AGENT; HEPATITIS ANTIBODY; VIRUS DNA; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS G VIRUS; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; REMISSION; TORQUE TENO VIRUS; ADOLESCENT; ADULT; AGED; BLOOD; FEMALE; GENETICS; HEPATITIS B; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; VIROLOGY; VIRUS HEPATITIS; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; DNA VIRUS INFECTIONS; DNA, VIRAL; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERFERONS; MALE; MIDDLE AGED; RNA, VIRAL; TORQUE TENO VIRUS;

EID: 3142735307     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Akahane, Y., Sakamato, M., Miyazaki, Y. és mtsai: Effect of interferon on non-enveloped DNA virus (TT virus) associated with acute and chronic hepatitis of unknown etiology. J. Med. Virol., 1999, 5, 196-200.
2. Alter, H. J.: Emerging hepatitis viruses. State-of-the-art lecture. XII. Falk Liver Week, Freiburg. 2003. Oct. 14-21.
3. Bjorman, P.; Widell, A., Veress, B. és mtsai: GB virus C/HGV infection in patients investigated for chronic liver disease and in the general population in southern Sweden. Scand. J. Infect. Dis., 2001, 33, 611-617.
4. Fehér J., Lengyel G.: Az újonnan felfedezett hepatitis vírusok epidemiológiája és klinikai jelentosége. Orv. Hetil., 1997, 138, 3-6.
5. Fodor B., Ladányi E., Alexa M. és mtsai: Hatással van-e a TT-vírus a hemodializált betegek T-sejt alcsoportjaira? Orv. Hetil., 2002, 143, 831-836.
6. Halasz, R., Weiland, O., Sallberg, M.: GB virus C/hepatitis G virus. Scand. J. Infect. Dis., 2001, 33, 72-580.
7. Hayashi, J., Ueno, K., Kawakami, Y. és mtsai: Clinical course of chronic hepatitis C virus infection is not influenced by concurrent hepatitis G virus infection. Dig. Dis. Sci., 1999, 44, 618-623.
8. Heringlake, S., Ockenga, J., Tillmann, H. L.: GB virus C/hepatitis G virus infection: a favourable prognostic factor in human immunodeficiency virus-infected patients? J. Infect. Dis. 1998, 177, 1723-1726.
9. Ikeda, H., Takasu, M., Inoue, K. és mtsai: Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for HCV RNA. J. Hepatol., 1999, 30, 205-212.
10. Ikeuchi, T., Yokosuka, O., Kanda, T. és mtsai: Roles of TT virus infection in various types of chronic hepatitis. Intervirology, 2001, 44, 219-223.
11. Inami, T., Konomi, N., Arakawa, Y.: High prevalence of TT virus DNA in human saliva and semen. J. Clin. Microbiol., 2000, 38, 2407-2408.
12. Kawanaka, M., Niiyama, G., Mahmood, S. és mtsai: Effect of TT virus co-infection on interferon response in chronic hepatitis C patients. Liver, 2002, 22, 351-355.
13. Khudyakov, Y. E., Cong, M. E., Bonafonte, M. T. és mtsai: Sequence variation within a nonstructural region of the hepatitis G virus genome. J. Virology, 1997, 71, 6875-6880.
14. Knodell, R. G., Ishak, K. G., Black, W. C. és mtsai: Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1981, 1, 431-435.
15. Linnen, J., Wages, Jr. J., Zhang-Keck, Z. Y. és mtsai: Molecular cloning and disease association of hepatitis G virus: a transfusion- transmissible agent. Science, 1996, 271, 505-508.
16. Mizokami, M., Albrecht, J. K., Kato, T. és mtsai: TT virus infection in patients with chronic hepatitis C virus infection - effects of primers, prevalence and clinical significance. J. Hepatol., 2000, 332, 339-343.
17. Moriyama, M., Matsumara, H., Shimizu, T. és mtsa: Hepatitis G virus coinfection influences the liver histology of patients with chronic hepatitis C. Liver, 2000, 2, 397-404.
18. Müller Zs., Deák J., Nagy E.: Hepatitis G virus - pathogén vagy endosymbionta? Infektológia és Klinikai Mikrobiológia, 2002, 9, 72-76.
19. Naumov, N. V.: TT virus - highly prevalent, but still in search of a disease. J. Hepatol., 2000, 33, 157-159.
20. Nemesánszky E., Csepregi A., Horányi M.: A hepatitis G/GB-C virus (Újabb fejezet a hepatotrop viruscsalád történetében.) Magy. Belorv. Arch., 1997, 50, 17-22.
21. Nishizawa, T., Okamoto, H., Konishi, K. és mtsai: A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys. Res. Comm., 1997, 241, 92-97.
22. Nordbo, S. A., Krokstad, S., Winge, P. és mtsai: Prevalence of GB virus C (also called hepatitis C virus) markers in Norwegian blood donors. J. Clin. Microbiol., 2000, 38, 2584-2590.
23. Okamoto, H., Akahanei, Y., Ukita, M. és mtsai: Fecal excretion of a nonenveloped DNA virus (TTV) associated with post-transfusion non-A-G hepatitis. J. Med. Virol., 1998, 56, 128-132.
24. Pár, A., Paál, M., Korányi, M. és mtsai: Role of viral and host factors in the pathogenesis of hepatitis C virus infection and in the response to interferon treatment. Period. Biol., 1998, 100, 515-519.
25. Pawlotsky, J. M., Dhumeaux, D.: The G virus: the orphan virus (In French) Press. Med., 1999, 28, 1882-1883.
26. Radfeowski, M., Kubicka, J., Kisiel, E. és mtsai (Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood, 2000, 95, 3986-3989.
27. Saiz, J. C., Ampurdanés, S., Olmedo, E. és mtsai: Hepatitis G virus infection in chronic hepatitis C frequency, features and response to interferon therapy. J. Hepatol., 1997, 26, 787-793.
28. Sambrook, J., Fritsch, E. F., Maniatis, T.: Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, USA. 1989.
29. Simons, J. N., Leary, T. P., Dawson, G. J. és mtsai: Isolation of novel virus-like sequences associated with human hepatitis. Nat. Med., 1995, 1, 564-569.
30. Springfield, C., Bugert, J. J., Schnitzler, P. és mtsai: TT virus as a human pathogen: significance and problems. Virus Genes, 2000, 20, 35-46.
31. Strauss, E., de Costa Gayotti, L. C., Fay, F. és mtsai: Liver histology in co-infection of hepatitis C virus (HCV) and hepatitis G virus (HGV). Rev. Inst. Med. Trop Sao Paolo, 2002, 44, 67-70.
32. Szabó A., Heemann U., Müller V. és mtsai: Hepatitis G virus infekció vesetranszplantált és dializált gyermek és felnott betegekben. Orv. Hetil., 1999, 140, 1619-1623.
33. Takács, M., Rusvai, E., Brojnás, J. és mtsai: A hepatitis G- és TT-virus diagnosztikájának bevezetése Magyarországon. LAM, 2001, 11, 274-282.
34. Takács, M., Szomor, K., Szendroi, A. és mtsai: Prevalence of GBV-C/HGV in Hungary. FEMS Immunol. Med. Microbiol., 2002, 34, 283-287.
35. Takács, M., Balog, K., Tóth, G. és mtsai: TT virus in Hungary: sequence heterogeneity and mixed infections. FEMS Immunology and Microbiology., 2003, 35, 153-157.
36. Takács M., Lengyel A., Dencs Á. és mtsa: Újonnan felfedezett hepatitisvirusok: de okoznak-e má jgyulladást? Orv. Hetil., 2003, 144, 1569-1574.
37. Tellier, R., Bukh, J., Emerson, S. U. és mtsai: Long PCR and its application to hepatitis viruses: amplification of hepatitis A, hepatitis B, and hepatitis C virus genomes. J. Clin., Microbiol., 1996, 34, 3085-3091.
38. Tillmann, H. L., Heiken, H., Knapik-Botor, A. és mtsai: Infection with GB virus C and reduced mortality among HIV-infected patients. N. Engl. J. Med., 2001, 345, 715-724.
39. Tokita, H., Murai, S., Kamitsukasa, H. és mtsai: High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease. J. Med. Virol., 2002, 67, 501-509.
40. Tucker, T. J:, Smuts, H. E., Eedes, C. és mtsai: Evidence that the GBV-C/hepatitis G virus is primarily a lymphotrophic virus. J. Med. Virol., 2000, 61, 52-58.
41. Tuveri, R., Jaffredo, F., Lunel, F. és mtsai: Impact of TT virus infection in acute and chronic viral- and non-viral-related liver diseases. J. Hepatol. 2000, 33, 121-127.
42. Watanabe, H., Saito. T., Kawamata, O: és mtsai: Clinical implications of TT virus superinfection in patients with chronic hepatitis C. Amer. J. Gastroenterol., 2000, 95, 1776-1780.
43. Xiang, J., Wünschmann, S., Diekema, D. J. és mtsai: Effect of coinfection with GB virus C on survival among patients with HIV infection. N. Engl., J. Med., 2001, 345, 707-714.
44. Zignego, A. L., Fontana, R., Puliti, S. és mtsai: Relevance of inapparent co-infection by hepatitis B virus in alpha interferon treated patients with hepatitis C virus chronic hepatitis. J. Med. Virol., 1997, 51, 313-318.